nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—ADRB1—stomach cancer	0.326	0.543	CbGaD
Indacaterol—ADRB2—stomach cancer	0.274	0.457	CbGaD
Indacaterol—UGT1A1—Irinotecan—stomach cancer	0.11	0.384	CbGbCtD
Indacaterol—ABCB1—Mitomycin—stomach cancer	0.0852	0.297	CbGbCtD
Indacaterol—ABCB1—Irinotecan—stomach cancer	0.0218	0.0762	CbGbCtD
Indacaterol—ABCB1—Docetaxel—stomach cancer	0.016	0.0559	CbGbCtD
Indacaterol—CYP3A4—Irinotecan—stomach cancer	0.0131	0.0457	CbGbCtD
Indacaterol—ABCB1—Doxorubicin—stomach cancer	0.0119	0.0417	CbGbCtD
Indacaterol—ABCB1—Methotrexate—stomach cancer	0.0116	0.0404	CbGbCtD
Indacaterol—CYP3A4—Docetaxel—stomach cancer	0.00959	0.0335	CbGbCtD
Indacaterol—CYP3A4—Doxorubicin—stomach cancer	0.00715	0.025	CbGbCtD
Indacaterol—Procaterol—ADRB2—stomach cancer	0.00421	1	CrCbGaD
Indacaterol—Dyspnoea—Mitomycin—stomach cancer	0.000599	0.00801	CcSEcCtD
Indacaterol—Hypokalaemia—Irinotecan—stomach cancer	0.00054	0.00722	CcSEcCtD
Indacaterol—Rash—Floxuridine—stomach cancer	0.00054	0.00722	CcSEcCtD
Indacaterol—Dermatitis—Floxuridine—stomach cancer	0.000539	0.00721	CcSEcCtD
Indacaterol—Headache—Floxuridine—stomach cancer	0.000536	0.00717	CcSEcCtD
Indacaterol—Nausea—Floxuridine—stomach cancer	0.000509	0.0068	CcSEcCtD
Indacaterol—Nasopharyngitis—Fluorouracil—stomach cancer	0.000508	0.0068	CcSEcCtD
Indacaterol—Angina pectoris—Irinotecan—stomach cancer	0.0005	0.00668	CcSEcCtD
Indacaterol—Angina pectoris—Fluorouracil—stomach cancer	0.000479	0.0064	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Irinotecan—stomach cancer	0.000477	0.00638	CcSEcCtD
Indacaterol—Pneumonia—Irinotecan—stomach cancer	0.00046	0.00615	CcSEcCtD
Indacaterol—Diabetes mellitus—Capecitabine—stomach cancer	0.000457	0.00611	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Fluorouracil—stomach cancer	0.000457	0.00611	CcSEcCtD
Indacaterol—Dizziness—Mitomycin—stomach cancer	0.000444	0.00594	CcSEcCtD
Indacaterol—Pneumonia—Fluorouracil—stomach cancer	0.000441	0.00589	CcSEcCtD
Indacaterol—Infestation NOS—Fluorouracil—stomach cancer	0.000438	0.00586	CcSEcCtD
Indacaterol—Infestation—Fluorouracil—stomach cancer	0.000438	0.00586	CcSEcCtD
Indacaterol—Atrial fibrillation—Docetaxel—stomach cancer	0.000433	0.00579	CcSEcCtD
Indacaterol—Rash—Mitomycin—stomach cancer	0.000424	0.00566	CcSEcCtD
Indacaterol—Dermatitis—Mitomycin—stomach cancer	0.000423	0.00566	CcSEcCtD
Indacaterol—Headache—Mitomycin—stomach cancer	0.000421	0.00563	CcSEcCtD
Indacaterol—Atrial fibrillation—Capecitabine—stomach cancer	0.000419	0.00561	CcSEcCtD
Indacaterol—Sinusitis—Fluorouracil—stomach cancer	0.000411	0.0055	CcSEcCtD
Indacaterol—Connective tissue disorder—Irinotecan—stomach cancer	0.000404	0.0054	CcSEcCtD
Indacaterol—Nausea—Mitomycin—stomach cancer	0.000399	0.00534	CcSEcCtD
Indacaterol—Musculoskeletal pain—Epirubicin—stomach cancer	0.000386	0.00516	CcSEcCtD
Indacaterol—Cardiac disorder—Irinotecan—stomach cancer	0.000381	0.0051	CcSEcCtD
Indacaterol—Immune system disorder—Irinotecan—stomach cancer	0.000371	0.00496	CcSEcCtD
Indacaterol—Mediastinal disorder—Irinotecan—stomach cancer	0.00037	0.00495	CcSEcCtD
Indacaterol—Nasopharyngitis—Docetaxel—stomach cancer	0.000367	0.00491	CcSEcCtD
Indacaterol—Hypokalaemia—Capecitabine—stomach cancer	0.000362	0.00483	CcSEcCtD
Indacaterol—Musculoskeletal pain—Doxorubicin—stomach cancer	0.000357	0.00477	CcSEcCtD
Indacaterol—Nasopharyngitis—Capecitabine—stomach cancer	0.000355	0.00475	CcSEcCtD
Indacaterol—Bronchospasm—Docetaxel—stomach cancer	0.000349	0.00466	CcSEcCtD
Indacaterol—Angina pectoris—Docetaxel—stomach cancer	0.000346	0.00462	CcSEcCtD
Indacaterol—Muscle spasms—Irinotecan—stomach cancer	0.000344	0.0046	CcSEcCtD
Indacaterol—Asthma—Capecitabine—stomach cancer	0.000343	0.00459	CcSEcCtD
Indacaterol—Diabetes mellitus—Methotrexate—stomach cancer	0.00034	0.00455	CcSEcCtD
Indacaterol—Bronchospasm—Capecitabine—stomach cancer	0.000338	0.00452	CcSEcCtD
Indacaterol—Angina pectoris—Capecitabine—stomach cancer	0.000335	0.00447	CcSEcCtD
Indacaterol—Anaemia—Irinotecan—stomach cancer	0.00033	0.00442	CcSEcCtD
Indacaterol—Vertigo—Irinotecan—stomach cancer	0.000321	0.00429	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000319	0.00427	CcSEcCtD
Indacaterol—Diabetes mellitus—Epirubicin—stomach cancer	0.000318	0.00425	CcSEcCtD
Indacaterol—Pneumonia—Docetaxel—stomach cancer	0.000318	0.00425	CcSEcCtD
Indacaterol—Anaemia—Fluorouracil—stomach cancer	0.000316	0.00423	CcSEcCtD
Indacaterol—Infestation NOS—Docetaxel—stomach cancer	0.000316	0.00423	CcSEcCtD
Indacaterol—Infestation—Docetaxel—stomach cancer	0.000316	0.00423	CcSEcCtD
Indacaterol—Cough—Irinotecan—stomach cancer	0.000312	0.00417	CcSEcCtD
Indacaterol—Hyperglycaemia—Capecitabine—stomach cancer	0.00031	0.00414	CcSEcCtD
Indacaterol—Pneumonia—Capecitabine—stomach cancer	0.000308	0.00412	CcSEcCtD
Indacaterol—Infestation NOS—Capecitabine—stomach cancer	0.000306	0.00409	CcSEcCtD
Indacaterol—Infestation—Capecitabine—stomach cancer	0.000306	0.00409	CcSEcCtD
Indacaterol—Diabetes mellitus—Doxorubicin—stomach cancer	0.000294	0.00394	CcSEcCtD
Indacaterol—Chest pain—Fluorouracil—stomach cancer	0.000292	0.0039	CcSEcCtD
Indacaterol—Myalgia—Fluorouracil—stomach cancer	0.000292	0.0039	CcSEcCtD
Indacaterol—Infection—Irinotecan—stomach cancer	0.00029	0.00388	CcSEcCtD
Indacaterol—Nervous system disorder—Irinotecan—stomach cancer	0.000286	0.00383	CcSEcCtD
Indacaterol—Oedema peripheral—Docetaxel—stomach cancer	0.00028	0.00374	CcSEcCtD
Indacaterol—Connective tissue disorder—Docetaxel—stomach cancer	0.000279	0.00373	CcSEcCtD
Indacaterol—Infection—Fluorouracil—stomach cancer	0.000278	0.00371	CcSEcCtD
Indacaterol—Nervous system disorder—Fluorouracil—stomach cancer	0.000274	0.00366	CcSEcCtD
Indacaterol—Tachycardia—Fluorouracil—stomach cancer	0.000273	0.00365	CcSEcCtD
Indacaterol—Oedema peripheral—Capecitabine—stomach cancer	0.000271	0.00362	CcSEcCtD
Indacaterol—Connective tissue disorder—Capecitabine—stomach cancer	0.00027	0.00361	CcSEcCtD
Indacaterol—Cardiac disorder—Docetaxel—stomach cancer	0.000263	0.00352	CcSEcCtD
Indacaterol—Paraesthesia—Irinotecan—stomach cancer	0.000262	0.0035	CcSEcCtD
Indacaterol—Dyspnoea—Irinotecan—stomach cancer	0.00026	0.00348	CcSEcCtD
Indacaterol—Immune system disorder—Docetaxel—stomach cancer	0.000256	0.00343	CcSEcCtD
Indacaterol—Mediastinal disorder—Docetaxel—stomach cancer	0.000256	0.00342	CcSEcCtD
Indacaterol—Asthma—Methotrexate—stomach cancer	0.000256	0.00342	CcSEcCtD
Indacaterol—Cardiac disorder—Capecitabine—stomach cancer	0.000255	0.00341	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000255	0.0034	CcSEcCtD
Indacaterol—Hypokalaemia—Epirubicin—stomach cancer	0.000252	0.00337	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000252	0.00337	CcSEcCtD
Indacaterol—Paraesthesia—Fluorouracil—stomach cancer	0.000251	0.00335	CcSEcCtD
Indacaterol—Dyspnoea—Fluorouracil—stomach cancer	0.000249	0.00333	CcSEcCtD
Indacaterol—Immune system disorder—Capecitabine—stomach cancer	0.000248	0.00332	CcSEcCtD
Indacaterol—Mediastinal disorder—Capecitabine—stomach cancer	0.000248	0.00331	CcSEcCtD
Indacaterol—Nasopharyngitis—Epirubicin—stomach cancer	0.000248	0.00331	CcSEcCtD
Indacaterol—Malnutrition—Docetaxel—stomach cancer	0.000247	0.0033	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000241	0.00323	CcSEcCtD
Indacaterol—Malnutrition—Capecitabine—stomach cancer	0.000239	0.0032	CcSEcCtD
Indacaterol—Asthma—Epirubicin—stomach cancer	0.000239	0.0032	CcSEcCtD
Indacaterol—Muscle spasms—Docetaxel—stomach cancer	0.000238	0.00318	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000238	0.00318	CcSEcCtD
Indacaterol—Hypokalaemia—Doxorubicin—stomach cancer	0.000233	0.00312	CcSEcCtD
Indacaterol—Angina pectoris—Epirubicin—stomach cancer	0.000233	0.00312	CcSEcCtD
Indacaterol—Muscle spasms—Capecitabine—stomach cancer	0.00023	0.00308	CcSEcCtD
Indacaterol—Pneumonia—Methotrexate—stomach cancer	0.000229	0.00307	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—stomach cancer	0.000229	0.00306	CcSEcCtD
Indacaterol—Anaemia—Docetaxel—stomach cancer	0.000228	0.00305	CcSEcCtD
Indacaterol—Infestation NOS—Methotrexate—stomach cancer	0.000228	0.00305	CcSEcCtD
Indacaterol—Infestation—Methotrexate—stomach cancer	0.000228	0.00305	CcSEcCtD
Indacaterol—Tremor—Capecitabine—stomach cancer	0.000224	0.003	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000222	0.00297	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—stomach cancer	0.000221	0.00296	CcSEcCtD
Indacaterol—Anaemia—Capecitabine—stomach cancer	0.000221	0.00296	CcSEcCtD
Indacaterol—Palpitations—Docetaxel—stomach cancer	0.000218	0.00292	CcSEcCtD
Indacaterol—Hyperglycaemia—Epirubicin—stomach cancer	0.000216	0.00289	CcSEcCtD
Indacaterol—Cough—Docetaxel—stomach cancer	0.000216	0.00288	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—stomach cancer	0.000216	0.00288	CcSEcCtD
Indacaterol—Vertigo—Capecitabine—stomach cancer	0.000215	0.00287	CcSEcCtD
Indacaterol—Hypersensitivity—Irinotecan—stomach cancer	0.000215	0.00287	CcSEcCtD
Indacaterol—Pneumonia—Epirubicin—stomach cancer	0.000215	0.00287	CcSEcCtD
Indacaterol—Infestation NOS—Epirubicin—stomach cancer	0.000213	0.00285	CcSEcCtD
Indacaterol—Infestation—Epirubicin—stomach cancer	0.000213	0.00285	CcSEcCtD
Indacaterol—Palpitations—Capecitabine—stomach cancer	0.000211	0.00283	CcSEcCtD
Indacaterol—Myalgia—Docetaxel—stomach cancer	0.00021	0.00281	CcSEcCtD
Indacaterol—Chest pain—Docetaxel—stomach cancer	0.00021	0.00281	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000209	0.00279	CcSEcCtD
Indacaterol—Cough—Capecitabine—stomach cancer	0.000209	0.00279	CcSEcCtD
Indacaterol—Hypersensitivity—Fluorouracil—stomach cancer	0.000206	0.00275	CcSEcCtD
Indacaterol—Dry mouth—Docetaxel—stomach cancer	0.000206	0.00275	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000206	0.00275	CcSEcCtD
Indacaterol—Myalgia—Capecitabine—stomach cancer	0.000204	0.00272	CcSEcCtD
Indacaterol—Chest pain—Capecitabine—stomach cancer	0.000204	0.00272	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000202	0.0027	CcSEcCtD
Indacaterol—Infection—Docetaxel—stomach cancer	0.0002	0.00268	CcSEcCtD
Indacaterol—Sinusitis—Epirubicin—stomach cancer	0.0002	0.00268	CcSEcCtD
Indacaterol—Hyperglycaemia—Doxorubicin—stomach cancer	0.0002	0.00267	CcSEcCtD
Indacaterol—Dry mouth—Capecitabine—stomach cancer	0.000199	0.00266	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—stomach cancer	0.000199	0.00265	CcSEcCtD
Indacaterol—Nervous system disorder—Docetaxel—stomach cancer	0.000198	0.00264	CcSEcCtD
Indacaterol—Pruritus—Fluorouracil—stomach cancer	0.000198	0.00264	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—stomach cancer	0.000197	0.00264	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—stomach cancer	0.000197	0.00264	CcSEcCtD
Indacaterol—Tachycardia—Docetaxel—stomach cancer	0.000197	0.00263	CcSEcCtD
Indacaterol—Skin disorder—Docetaxel—stomach cancer	0.000196	0.00262	CcSEcCtD
Indacaterol—Infection—Capecitabine—stomach cancer	0.000194	0.00259	CcSEcCtD
Indacaterol—Dizziness—Irinotecan—stomach cancer	0.000193	0.00258	CcSEcCtD
Indacaterol—Nervous system disorder—Capecitabine—stomach cancer	0.000192	0.00256	CcSEcCtD
Indacaterol—Tachycardia—Capecitabine—stomach cancer	0.000191	0.00255	CcSEcCtD
Indacaterol—Cardiac disorder—Methotrexate—stomach cancer	0.00019	0.00254	CcSEcCtD
Indacaterol—Skin disorder—Capecitabine—stomach cancer	0.00019	0.00254	CcSEcCtD
Indacaterol—Oedema peripheral—Epirubicin—stomach cancer	0.000189	0.00252	CcSEcCtD
Indacaterol—Connective tissue disorder—Epirubicin—stomach cancer	0.000188	0.00252	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—stomach cancer	0.000185	0.00248	CcSEcCtD
Indacaterol—Immune system disorder—Methotrexate—stomach cancer	0.000185	0.00247	CcSEcCtD
Indacaterol—Dizziness—Fluorouracil—stomach cancer	0.000185	0.00247	CcSEcCtD
Indacaterol—Mediastinal disorder—Methotrexate—stomach cancer	0.000184	0.00247	CcSEcCtD
Indacaterol—Rash—Irinotecan—stomach cancer	0.000184	0.00246	CcSEcCtD
Indacaterol—Dermatitis—Irinotecan—stomach cancer	0.000184	0.00246	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000184	0.00246	CcSEcCtD
Indacaterol—Headache—Irinotecan—stomach cancer	0.000183	0.00244	CcSEcCtD
Indacaterol—Paraesthesia—Docetaxel—stomach cancer	0.000181	0.00242	CcSEcCtD
Indacaterol—Dyspnoea—Docetaxel—stomach cancer	0.00018	0.0024	CcSEcCtD
Indacaterol—Malnutrition—Methotrexate—stomach cancer	0.000178	0.00238	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000178	0.00238	CcSEcCtD
Indacaterol—Cardiac disorder—Epirubicin—stomach cancer	0.000178	0.00238	CcSEcCtD
Indacaterol—Rash—Fluorouracil—stomach cancer	0.000176	0.00236	CcSEcCtD
Indacaterol—Dermatitis—Fluorouracil—stomach cancer	0.000176	0.00235	CcSEcCtD
Indacaterol—Paraesthesia—Capecitabine—stomach cancer	0.000175	0.00234	CcSEcCtD
Indacaterol—Headache—Fluorouracil—stomach cancer	0.000175	0.00234	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—stomach cancer	0.000175	0.00233	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000174	0.00233	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—stomach cancer	0.000174	0.00233	CcSEcCtD
Indacaterol—Dyspnoea—Capecitabine—stomach cancer	0.000174	0.00233	CcSEcCtD
Indacaterol—Nausea—Irinotecan—stomach cancer	0.000173	0.00232	CcSEcCtD
Indacaterol—Immune system disorder—Epirubicin—stomach cancer	0.000173	0.00231	CcSEcCtD
Indacaterol—Mediastinal disorder—Epirubicin—stomach cancer	0.000173	0.00231	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000169	0.00225	CcSEcCtD
Indacaterol—Malnutrition—Epirubicin—stomach cancer	0.000167	0.00223	CcSEcCtD
Indacaterol—Nausea—Fluorouracil—stomach cancer	0.000166	0.00222	CcSEcCtD
Indacaterol—Anaemia—Methotrexate—stomach cancer	0.000165	0.0022	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—stomach cancer	0.000164	0.0022	CcSEcCtD
Indacaterol—Muscle spasms—Epirubicin—stomach cancer	0.00016	0.00214	CcSEcCtD
Indacaterol—Immune system disorder—Doxorubicin—stomach cancer	0.00016	0.00214	CcSEcCtD
Indacaterol—Vertigo—Methotrexate—stomach cancer	0.00016	0.00214	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—stomach cancer	0.00016	0.00213	CcSEcCtD
Indacaterol—Cough—Methotrexate—stomach cancer	0.000155	0.00208	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—stomach cancer	0.000154	0.00206	CcSEcCtD
Indacaterol—Anaemia—Epirubicin—stomach cancer	0.000154	0.00206	CcSEcCtD
Indacaterol—Chest pain—Methotrexate—stomach cancer	0.000152	0.00203	CcSEcCtD
Indacaterol—Myalgia—Methotrexate—stomach cancer	0.000152	0.00203	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000151	0.00201	CcSEcCtD
Indacaterol—Vertigo—Epirubicin—stomach cancer	0.00015	0.002	CcSEcCtD
Indacaterol—Hypersensitivity—Docetaxel—stomach cancer	0.000149	0.00199	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—stomach cancer	0.000148	0.00198	CcSEcCtD
Indacaterol—Palpitations—Epirubicin—stomach cancer	0.000147	0.00197	CcSEcCtD
Indacaterol—Cough—Epirubicin—stomach cancer	0.000145	0.00194	CcSEcCtD
Indacaterol—Infection—Methotrexate—stomach cancer	0.000144	0.00193	CcSEcCtD
Indacaterol—Hypersensitivity—Capecitabine—stomach cancer	0.000144	0.00192	CcSEcCtD
Indacaterol—Pruritus—Docetaxel—stomach cancer	0.000143	0.00191	CcSEcCtD
Indacaterol—Nervous system disorder—Methotrexate—stomach cancer	0.000143	0.00191	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—stomach cancer	0.000143	0.00191	CcSEcCtD
Indacaterol—Myalgia—Epirubicin—stomach cancer	0.000142	0.0019	CcSEcCtD
Indacaterol—Chest pain—Epirubicin—stomach cancer	0.000142	0.0019	CcSEcCtD
Indacaterol—Skin disorder—Methotrexate—stomach cancer	0.000141	0.00189	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000141	0.00188	CcSEcCtD
Indacaterol—Dry mouth—Epirubicin—stomach cancer	0.000139	0.00186	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—stomach cancer	0.000139	0.00185	CcSEcCtD
Indacaterol—Pruritus—Capecitabine—stomach cancer	0.000138	0.00185	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—stomach cancer	0.000136	0.00182	CcSEcCtD
Indacaterol—Infection—Epirubicin—stomach cancer	0.000135	0.00181	CcSEcCtD
Indacaterol—Cough—Doxorubicin—stomach cancer	0.000135	0.0018	CcSEcCtD
Indacaterol—Nervous system disorder—Epirubicin—stomach cancer	0.000133	0.00178	CcSEcCtD
Indacaterol—Dizziness—Docetaxel—stomach cancer	0.000133	0.00178	CcSEcCtD
Indacaterol—Tachycardia—Epirubicin—stomach cancer	0.000133	0.00178	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000132	0.00177	CcSEcCtD
Indacaterol—Skin disorder—Epirubicin—stomach cancer	0.000132	0.00177	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—stomach cancer	0.000131	0.00176	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—stomach cancer	0.000131	0.00176	CcSEcCtD
Indacaterol—Paraesthesia—Methotrexate—stomach cancer	0.000131	0.00175	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00013	0.00174	CcSEcCtD
Indacaterol—Dyspnoea—Methotrexate—stomach cancer	0.00013	0.00173	CcSEcCtD
Indacaterol—Dizziness—Capecitabine—stomach cancer	0.000129	0.00173	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—stomach cancer	0.000128	0.00172	CcSEcCtD
Indacaterol—Rash—Docetaxel—stomach cancer	0.000127	0.0017	CcSEcCtD
Indacaterol—Dermatitis—Docetaxel—stomach cancer	0.000127	0.0017	CcSEcCtD
Indacaterol—Headache—Docetaxel—stomach cancer	0.000126	0.00169	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000126	0.00168	CcSEcCtD
Indacaterol—Infection—Doxorubicin—stomach cancer	0.000125	0.00167	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000124	0.00166	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—stomach cancer	0.000123	0.00165	CcSEcCtD
Indacaterol—Rash—Capecitabine—stomach cancer	0.000123	0.00165	CcSEcCtD
Indacaterol—Dermatitis—Capecitabine—stomach cancer	0.000123	0.00164	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—stomach cancer	0.000123	0.00164	CcSEcCtD
Indacaterol—Headache—Capecitabine—stomach cancer	0.000122	0.00164	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—stomach cancer	0.000122	0.00163	CcSEcCtD
Indacaterol—Paraesthesia—Epirubicin—stomach cancer	0.000122	0.00163	CcSEcCtD
Indacaterol—Dyspnoea—Epirubicin—stomach cancer	0.000121	0.00162	CcSEcCtD
Indacaterol—Nausea—Docetaxel—stomach cancer	0.00012	0.0016	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000117	0.00157	CcSEcCtD
Indacaterol—Nausea—Capecitabine—stomach cancer	0.000116	0.00155	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000115	0.00153	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—stomach cancer	0.000113	0.00151	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—stomach cancer	0.000112	0.0015	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000109	0.00145	CcSEcCtD
Indacaterol—Hypersensitivity—Methotrexate—stomach cancer	0.000107	0.00143	CcSEcCtD
Indacaterol—Pruritus—Methotrexate—stomach cancer	0.000103	0.00138	CcSEcCtD
Indacaterol—Hypersensitivity—Epirubicin—stomach cancer	0.0001	0.00134	CcSEcCtD
Indacaterol—Pruritus—Epirubicin—stomach cancer	9.63e-05	0.00129	CcSEcCtD
Indacaterol—Dizziness—Methotrexate—stomach cancer	9.61e-05	0.00129	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—stomach cancer	9.27e-05	0.00124	CcSEcCtD
Indacaterol—Rash—Methotrexate—stomach cancer	9.17e-05	0.00123	CcSEcCtD
Indacaterol—Dermatitis—Methotrexate—stomach cancer	9.16e-05	0.00122	CcSEcCtD
Indacaterol—Headache—Methotrexate—stomach cancer	9.11e-05	0.00122	CcSEcCtD
Indacaterol—Dizziness—Epirubicin—stomach cancer	9e-05	0.0012	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—stomach cancer	8.91e-05	0.00119	CcSEcCtD
Indacaterol—Nausea—Methotrexate—stomach cancer	8.64e-05	0.00115	CcSEcCtD
Indacaterol—Rash—Epirubicin—stomach cancer	8.58e-05	0.00115	CcSEcCtD
Indacaterol—Dermatitis—Epirubicin—stomach cancer	8.57e-05	0.00115	CcSEcCtD
Indacaterol—Headache—Epirubicin—stomach cancer	8.52e-05	0.00114	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—stomach cancer	8.32e-05	0.00111	CcSEcCtD
Indacaterol—Nausea—Epirubicin—stomach cancer	8.08e-05	0.00108	CcSEcCtD
Indacaterol—Rash—Doxorubicin—stomach cancer	7.94e-05	0.00106	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—stomach cancer	7.93e-05	0.00106	CcSEcCtD
Indacaterol—Headache—Doxorubicin—stomach cancer	7.89e-05	0.00105	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—stomach cancer	7.48e-05	0.001	CcSEcCtD
Indacaterol—UGT1A1—Metabolism—ENO1—stomach cancer	1.77e-05	0.000513	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NDUFA2—stomach cancer	1.73e-05	0.000502	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CA1—stomach cancer	1.73e-05	0.000502	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—FBP1—stomach cancer	1.73e-05	0.000502	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CKB—stomach cancer	1.73e-05	0.000502	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGG—stomach cancer	1.72e-05	0.000499	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	1.71e-05	0.000496	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	1.7e-05	0.000493	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGG—stomach cancer	1.69e-05	0.000488	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	1.67e-05	0.000485	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	1.67e-05	0.000483	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	1.66e-05	0.000481	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GMPR2—stomach cancer	1.66e-05	0.00048	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	1.63e-05	0.000473	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PLIN2—stomach cancer	1.63e-05	0.000472	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	1.62e-05	0.00047	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RBP4—stomach cancer	1.6e-05	0.000464	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	1.6e-05	0.000464	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CA2—stomach cancer	1.59e-05	0.00046	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	1.58e-05	0.000459	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CD44—stomach cancer	1.57e-05	0.000455	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RBP4—stomach cancer	1.57e-05	0.000454	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	1.57e-05	0.000454	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PGAM1—stomach cancer	1.55e-05	0.000448	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NT5E—stomach cancer	1.55e-05	0.000448	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—IDH3B—stomach cancer	1.52e-05	0.000439	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.52e-05	0.000439	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	1.51e-05	0.000438	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	1.51e-05	0.000437	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALDH7A1—stomach cancer	1.47e-05	0.000427	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PLCE1—stomach cancer	1.47e-05	0.000427	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.46e-05	0.000424	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.43e-05	0.000414	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—UMPS—stomach cancer	1.41e-05	0.00041	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.41e-05	0.000408	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.41e-05	0.000408	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	1.38e-05	0.000399	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	1.38e-05	0.000399	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—BMP2—stomach cancer	1.36e-05	0.000395	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—F2R—stomach cancer	1.36e-05	0.000395	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	1.35e-05	0.00039	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	1.35e-05	0.00039	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	1.34e-05	0.000388	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PPP2R1A—stomach cancer	1.33e-05	0.000387	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—BMP2—stomach cancer	1.33e-05	0.000386	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—F2R—stomach cancer	1.33e-05	0.000386	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	1.33e-05	0.000384	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.32e-05	0.000382	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PDHA1—stomach cancer	1.31e-05	0.000381	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ECHS1—stomach cancer	1.31e-05	0.000381	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	1.31e-05	0.00038	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GSTP1—stomach cancer	1.31e-05	0.000379	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	1.3e-05	0.000376	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—HMOX1—stomach cancer	1.29e-05	0.000374	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	1.28e-05	0.000372	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	1.28e-05	0.000371	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.26e-05	0.000366	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PGLS—stomach cancer	1.26e-05	0.000364	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—BLVRB—stomach cancer	1.26e-05	0.000364	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	1.26e-05	0.000364	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	1.25e-05	0.000363	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.25e-05	0.000361	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—TYMP—stomach cancer	1.24e-05	0.000358	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—FADS1—stomach cancer	1.24e-05	0.000358	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—TYMS—stomach cancer	1.22e-05	0.000353	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	1.21e-05	0.000352	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.21e-05	0.000351	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GSTM1—stomach cancer	1.2e-05	0.000349	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.2e-05	0.000347	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.19e-05	0.000344	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.19e-05	0.000344	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RPS6—stomach cancer	1.18e-05	0.000343	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	1.17e-05	0.000338	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	1.16e-05	0.000336	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RPS6—stomach cancer	1.16e-05	0.000336	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SREBF2—stomach cancer	1.16e-05	0.000335	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—RORA—stomach cancer	1.14e-05	0.000331	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	1.14e-05	0.00033	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	1.14e-05	0.000329	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ERCC2—stomach cancer	1.13e-05	0.000328	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.13e-05	0.000327	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.12e-05	0.000325	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	1.09e-05	0.000316	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALDOB—stomach cancer	1.07e-05	0.00031	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—FBP1—stomach cancer	1.07e-05	0.00031	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.07e-05	0.00031	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CKB—stomach cancer	1.07e-05	0.00031	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CA1—stomach cancer	1.07e-05	0.00031	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	1.06e-05	0.000309	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—MTHFR—stomach cancer	1.06e-05	0.000308	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	1.04e-05	0.0003	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	1.03e-05	0.000299	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.03e-05	0.000298	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	1.01e-05	0.000294	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	1.01e-05	0.000292	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	1e-05	0.000291	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PLIN2—stomach cancer	1e-05	0.000291	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALOX5—stomach cancer	9.96e-06	0.000289	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	9.96e-06	0.000289	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	9.85e-06	0.000285	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CAV1—stomach cancer	9.8e-06	0.000284	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—DPYD—stomach cancer	9.8e-06	0.000284	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—APOA1—stomach cancer	9.78e-06	0.000284	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CA2—stomach cancer	9.77e-06	0.000283	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	9.63e-06	0.000279	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	9.58e-06	0.000278	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NT5E—stomach cancer	9.52e-06	0.000276	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PGAM1—stomach cancer	9.52e-06	0.000276	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	9.36e-06	0.000271	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	9.15e-06	0.000265	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	9.14e-06	0.000265	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PLCE1—stomach cancer	9.08e-06	0.000263	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALDH7A1—stomach cancer	9.08e-06	0.000263	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	9.05e-06	0.000262	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	8.94e-06	0.000259	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	8.85e-06	0.000256	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—UMPS—stomach cancer	8.71e-06	0.000252	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FYN—stomach cancer	8.68e-06	0.000252	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTT1—stomach cancer	8.66e-06	0.000251	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PPARG—stomach cancer	8.62e-06	0.00025	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP2A6—stomach cancer	8.56e-06	0.000248	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FYN—stomach cancer	8.49e-06	0.000246	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AKR1C3—stomach cancer	8.33e-06	0.000241	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	8.21e-06	0.000238	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	8.15e-06	0.000236	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ENO1—stomach cancer	8.12e-06	0.000235	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PDHA1—stomach cancer	8.09e-06	0.000235	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ECHS1—stomach cancer	8.09e-06	0.000235	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	8.04e-06	0.000233	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	7.97e-06	0.000231	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ALB—stomach cancer	7.75e-06	0.000225	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—TYMP—stomach cancer	7.61e-06	0.000221	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—FADS1—stomach cancer	7.61e-06	0.000221	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	7.59e-06	0.00022	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IRS2—stomach cancer	7.46e-06	0.000216	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—NOS3—stomach cancer	7.41e-06	0.000215	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IRS2—stomach cancer	7.3e-06	0.000212	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CAV1—stomach cancer	7.23e-06	0.00021	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APOA1—stomach cancer	7.22e-06	0.000209	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CD44—stomach cancer	7.2e-06	0.000209	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SREBF2—stomach cancer	7.13e-06	0.000207	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CAV1—stomach cancer	7.08e-06	0.000205	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APOA1—stomach cancer	7.06e-06	0.000205	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—RORA—stomach cancer	7.04e-06	0.000204	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	6.89e-06	0.0002	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	6.86e-06	0.000199	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTGS2—stomach cancer	6.78e-06	0.000197	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	6.74e-06	0.000195	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	6.71e-06	0.000194	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALDOB—stomach cancer	6.6e-06	0.000191	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APC—stomach cancer	6.59e-06	0.000191	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APC—stomach cancer	6.45e-06	0.000187	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	6.31e-06	0.000183	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	6.17e-06	0.000179	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALOX5—stomach cancer	6.13e-06	0.000178	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PPP2R1A—stomach cancer	6.12e-06	0.000177	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6R—stomach cancer	6.12e-06	0.000177	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—DPYD—stomach cancer	6.04e-06	0.000175	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	6e-06	0.000174	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTP1—stomach cancer	6e-06	0.000174	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	6e-06	0.000174	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6R—stomach cancer	5.99e-06	0.000173	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—HMOX1—stomach cancer	5.92e-06	0.000172	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	5.87e-06	0.00017	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	5.87e-06	0.00017	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	5.74e-06	0.000166	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	5.73e-06	0.000166	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	5.67e-06	0.000164	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	5.61e-06	0.000163	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	5.6e-06	0.000162	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—TYMS—stomach cancer	5.58e-06	0.000162	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	5.55e-06	0.000161	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RHOA—stomach cancer	5.53e-06	0.00016	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTM1—stomach cancer	5.52e-06	0.00016	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOS3—stomach cancer	5.47e-06	0.000159	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RHOA—stomach cancer	5.41e-06	0.000157	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOS3—stomach cancer	5.35e-06	0.000155	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTT1—stomach cancer	5.34e-06	0.000155	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP2A6—stomach cancer	5.28e-06	0.000153	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	5.21e-06	0.000151	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ERCC2—stomach cancer	5.19e-06	0.00015	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AKR1C3—stomach cancer	5.13e-06	0.000149	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	5.12e-06	0.000148	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	5.1e-06	0.000148	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	5.01e-06	0.000145	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ENO1—stomach cancer	5e-06	0.000145	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—MTHFR—stomach cancer	4.88e-06	0.000141	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	4.85e-06	0.000141	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	4.82e-06	0.00014	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	4.75e-06	0.000138	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	4.74e-06	0.000137	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	4.72e-06	0.000137	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	4.64e-06	0.000134	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6—stomach cancer	4.61e-06	0.000134	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCND1—stomach cancer	4.52e-06	0.000131	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6—stomach cancer	4.51e-06	0.000131	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JUN—stomach cancer	4.51e-06	0.000131	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CAV1—stomach cancer	4.5e-06	0.00013	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—APOA1—stomach cancer	4.49e-06	0.00013	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CD44—stomach cancer	4.44e-06	0.000129	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCND1—stomach cancer	4.42e-06	0.000128	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JUN—stomach cancer	4.41e-06	0.000128	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MMP9—stomach cancer	4.39e-06	0.000127	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	4.37e-06	0.000127	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MMP9—stomach cancer	4.29e-06	0.000124	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	4.28e-06	0.000124	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	4.27e-06	0.000124	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	4.18e-06	0.000121	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CA—stomach cancer	4.17e-06	0.000121	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PPARG—stomach cancer	3.95e-06	0.000115	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	3.94e-06	0.000114	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—STAT3—stomach cancer	3.9e-06	0.000113	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	3.86e-06	0.000112	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—STAT3—stomach cancer	3.82e-06	0.000111	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.77e-06	0.000109	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	3.73e-06	0.000108	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTP1—stomach cancer	3.7e-06	0.000107	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HMOX1—stomach cancer	3.65e-06	0.000106	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	3.65e-06	0.000106	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MYC—stomach cancer	3.63e-06	0.000105	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALB—stomach cancer	3.56e-06	0.000103	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	3.55e-06	0.000103	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MYC—stomach cancer	3.55e-06	0.000103	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EGFR—stomach cancer	3.55e-06	0.000103	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	3.47e-06	0.000101	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EGFR—stomach cancer	3.47e-06	0.000101	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—TYMS—stomach cancer	3.44e-06	9.97e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NOS3—stomach cancer	3.4e-06	9.86e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTM1—stomach cancer	3.4e-06	9.85e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KRAS—stomach cancer	3.35e-06	9.71e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KRAS—stomach cancer	3.28e-06	9.5e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ERCC2—stomach cancer	3.2e-06	9.26e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTGS2—stomach cancer	3.11e-06	9.02e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	3.08e-06	8.92e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	3.01e-06	8.73e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MTHFR—stomach cancer	3e-06	8.71e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TP53—stomach cancer	2.98e-06	8.63e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TP53—stomach cancer	2.91e-06	8.44e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HRAS—stomach cancer	2.85e-06	8.25e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HRAS—stomach cancer	2.79e-06	8.07e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CAV1—stomach cancer	2.77e-06	8.03e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—APOA1—stomach cancer	2.76e-06	8.01e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6—stomach cancer	2.73e-06	7.9e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6—stomach cancer	2.67e-06	7.73e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPARG—stomach cancer	2.44e-06	7.06e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALB—stomach cancer	2.19e-06	6.35e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NOS3—stomach cancer	2.1e-06	6.07e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTGS2—stomach cancer	1.92e-06	5.55e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CA—stomach cancer	1.91e-06	5.55e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.18e-06	3.42e-05	CbGpPWpGaD
